[an error occurred while processing this directive]
临床研究

尿毒症患者异常升高的甲状旁腺激素水平与营养和衰弱状态的关系研究

  • 李莹莹 ,
  • 李靖 ,
  • 邢广群
展开
  • 1青岛大学附属医院肾病科

收稿日期: 2021-04-26

  修回日期: 2021-07-07

  网络出版日期: 2021-09-12

基金资助

青岛市科技局成果转化计划科技惠民专项(15-9-2-90-nsh);
青岛市卫生健康委员会优秀学科带头人培养计划(3565)

Study on the relationship between the abnormally elevated level of parathyroid hormone and the status of nutrition and debilitating in uremia patients#br#

  • LI Ying-Ying ,
  • LI Jing ,
  • XING Guang-Qun
Expand
  • 1Department of Nephrology, the Affiliated Hospital of Qingdao University, #1677, Wutai Shan Road, Qingdao 266555, Shandong
    Province, China

Received date: 2021-04-26

  Revised date: 2021-07-07

  Online published: 2021-09-12

摘要

【摘要】目的在尿毒症甲状旁腺腺瘤形成行甲状旁腺切除术(parathyroidectomy,PTX)的患者中,探讨异常增高的甲状旁腺激素水平与营养状态之间的关系。方法回顾性分析2015 年9 月~2020 年7 月在青岛大学附属医院行PTX 的患者118 例,分析手术前1 周及手术后半年透析前全段甲状旁腺激素(iPTH)、血钙、血磷、碱性磷酸酶及体质量指数、血白蛋白等营养相关的临床指标,采用主观全面营养评估法(subjective global assessment,SGA) 及Edmonton 衰弱评分量表对患者行营养评估。结果iPTH (Z=-7.940、P<0.001)、血钙(Z=-9.101、P<0.001)、血磷(Z=-8.396、P<0.001)、碱性磷酸酶(Z=-8.367、P<0.001)、血白蛋白(Z=-7.940、P<0.001)、前白蛋白(Z=-5.102、P<0.001)、体质量指数(Z=-7.341、P<0.001)等指标手术前后存在统计学差异。SGA 评分及Edmonton 评分显示术后营养不良及衰弱状态改善。手术前iPTH 水平与体质量指数(r =-0.272、P=0.003)、血白蛋白(r =-0.630、P<0.001)、前白蛋白
(r =-0.165、P=0.020)及SGA评分(r =-0.781、P<0.001)呈负相关,与Edmonton评分(r =0.611、P<0.001)呈正相关。结论尿毒症继发性甲状旁腺腺瘤甲状旁腺切除的患者手术前后营养状况差异显著,手术后患者iPTH显著降低,营养相关指标显著改善,衰弱状态显著纠正。

本文引用格式

李莹莹 , 李靖 , 邢广群 . 尿毒症患者异常升高的甲状旁腺激素水平与营养和衰弱状态的关系研究[J]. 中国血液净化, 2021 , 20(09) : 608 -611 . DOI: 10.3969/j.issn.1671-4091.2021.09.008

Abstract

【Abstract】Objective To investigate the relationship between abnormally elevated parathyroid hormone level and nutritional status in uremia patients with parathyroid adenoma undergoing parathyroidectomy (PTX). Methods A total of 118 uremia patients with uremia hyperparathyroidism undergoing PTX treated in the Affiliated Hospital of Qingdao University during September 2015 to July 2020 were retrospectively analyzed. Their intact parathyroid hormone (iPTH), serum calcium, phosphate and alkaline phosphatase and the nutrition-related indexes of BMI and serum albumin one week before PTX and after PTX for 6 months were
collected and analyzed. Subjective global assessment (SGA) and Edmonton scoring for debilitating were used for the assessment of nutritional status. Results There were significant differences in serum iPTH (Z=-7.940, P<0.001), calcium (Z=-9.101, P<0.001), phosphate (Z=-8.396, P<0.001), alkaline phosphatase (Z=-8.367, P<0.001), albumin (Z=-7.940, P<0.001) prealbumin (Z= -5.102, P<0.001) and BMI (Z=-7.341, P<0.001) before and after PTX. The changes of SGA score and Edmonton score indicated the improvement of nutrition and debilitating status after PTX. The preoperative iPTH level was negatively correlated with BMI (r=-0.272, P=0.003), serum albumin (r=-0.630, P<0.001), prealbumin (r=-0.165, P=0.020) and SGA scores (r=-0.781, P<0.001), and positively correlated with Edmonton score (r=0.611, P<0.001). Conclusion The nutritional status was significantly different before and after PTX in uremia patients with hyperparathyroidism. Serum iPTH reduced, and nutrition indexes and debilitating status improved significantly after PTX.

参考文献

[1]Cunningham J, Locatelli F, Rodriguez M.Secondary Hyperparathyroidism:Pathogenesis,Disease Progression,and Therapeutic Options[J].Clinical Journal of the American Society of Nephrology Cjasn, 2011, 6(4):913-21 [2]王莉, 李贵森, 刘志红.中华医学会肾脏病学分会《慢性肾脏病矿物质和骨异常诊治指导》[J].肾脏病与透析肾移植杂志, 2013, 22(6):554-559 [3]Tentori, F, et al..Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis:the DOPPS study[J].[J].Clinical Journal of the American Society of Nephrology Cjasn, 2015, 10(1):98-109 [4]Vazquez-Rodriguez, B I., et al..Metabolic therapy with iodine 131 in patients with chronic renal failure Clinical case[J][J].Enferm Clin, 2015, 25(6):348-54 [5]Cuppari, L.Increased resting energy expenditure in hemodialysis patients with severe hyperparathyroidism[J].Journal of the American Society of Nephrology Jasn, 2004, 15(11):2933- [6].KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)[J].Kidney Int Suppl, 2009, 113:S1-130- [7]Nagy E, Mahmoud M, Ghada El annishy, et al.The impact of malnutrition on health‐related quality of life in patients on maintenance hemodialysis[J].[J].Therapeutic Apheresis and Dialysis, 2020, :1744-9979 [8]Rolfson, D B., et al..Validity and reliability of the Edmonton Frail Scale[J][J]..Age& Ageing, 2006, .35(5):526-9 [9]贾彦诺等.慢性肾衰竭继发性甲状旁腺功能亢进的相关因素分析及治疗[J].中国老年学杂志, 2015, 35(11):3182-3184 [10]Masmoudi A, Darouiche M H, Salah H B, et al.Cutaneous abnormalities in patients with end stage renal failure on chronic hemodialysisA study of 458 patients.[J].Journal of Dermatological Case Reports, 2011, 8(4):86- [11]Dring, B and V.Hipkiss.Managing and treating chronic kidney disease[J].[J].Nurs Times, 2015, 111(7):16-9 [12]He, Y, et al..The browning of white adipose tissue and body weight loss in primary hyperparathyroidism[J][J].EBioMedicine, 2019, 40:56-66 [13]Koppe, L, D.Fouque and K.Kalantar-Zadeh..Kidney cachexia or protein-energy wasting in chronic kidney disease: facts and numbers[J].[J].J Cachexia Sarcopenia Muscle, 2019, 10(3):479-484 [14]Komaba, H and M.Fukagawa..Secondary Hyperparathyroidism and Protein-Energy Wasting in End-Stage Renal Disease[J][J].therapeutic apheresis and dialysis, 2018, 22(3):246-250 [15]Kir, S, et al..PTH/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer[J].Cell Metabolism,, 2016, 23(2):315-23 [16]Kir, S, et al..Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia[J][J].Nature, 2014, 513(7516):100-4 [17]Wyatt, C M.and W.E.Mitch..In experimental chronic kidney disease or cancer, parathyroid hormone is a novel mediator ofcachexia[J].[J].Kidney International, 2016, 89(5):973-975 [18]陈香美, 倪兆慧, 刘玉宁, 等.慢性肾衰竭中西医结合诊疗指南[J].[J].中国中西医结合杂志, 2015, (09):1029-1033
文章导航

/

[an error occurred while processing this directive]